Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
NCT00004893
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
BIOLOGICAL:
recombinant interleukin-12
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
[object Object]